Sabine Schneider
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Sabine Schneider has a total of 77 co-authors. Here are the top co-authors by number of shared publications:
- Robert O. Heuckeroth
Children’s Hospital of Philadelphia Research Institute and Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA
7 shared publications - Christina M. Wright
Children’s Hospital of Philadelphia Research Institute and Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA
6 shared publications - Sohaib Khalid Hashmi
The Children’s Hospital of Philadelphia Research Institute and the Abramson Research Center, Philadelphia, Pennsylvania, USA
2 shared publications - A. Josephine Thrasher
Department of Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA 19104, USA
1 shared publication - Aaron S. Zelikovich
Department of Neurology, Weill Cornell Medicine, New York, NY
1 shared publication - Abigail K. R. Lytton-Jean
David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA
1 shared publication
Latest Publications
- 9 September 2025
- Published by Wolters Kluwer Health in Neurology
- Vol. 105 (5) , e213994
Clinical Reasoning: A 72-Year-Old Man With Progressive Pan-Dysautonomia
Dysautonomia is a common clinical feature among many central and peripheral neurologic disorders. Evaluation of patients with dysautonomia can be challenging in the absence of a previously established neurologic diagnosis. In this case, we discuss a 72-year-old man who presented with 9 months of progressive dysautonomia including orthostatic hypotension, urinary retention, erectile dysfunction, and constipation. A combination of autonomic testing and serologic testing confirmed the final diagnosis. This case highlights the differential diagnosis of autonomic failure, emphasizing the role of specific clinical, laboratory, and imaging cues in guiding clinical reasoning.
- 9 September 2025
- Published by Wolters Kluwer Health in Neurology
- Vol. 105 (5) , e213994
Clinical Reasoning: A 72-Year-Old Man With Progressive Pan-Dysautonomia
Dysautonomia is a common clinical feature among many central and peripheral neurologic disorders. Evaluation of patients with dysautonomia can be challenging in the absence of a previously established neurologic diagnosis. In this case, we discuss a 72-year-old man who presented with 9 months of progressive dysautonomia including orthostatic hypotension, urinary retention, erectile dysfunction, and constipation. A combination of autonomic testing and serologic testing confirmed the final diagnosis. This case highlights the differential diagnosis of autonomic failure, emphasizing the role of specific clinical, laboratory, and imaging cues in guiding clinical reasoning.
- Open Access
- 21 October 2024
- Published by Wiley in Movement Disorders Clinical Practice
- Vol. 11 (12) , 1625-1628
Parkinsonism Associated with Anti‐B‐Cell Maturation Antigen Chimeric Antigen Receptor T‐Cell Therapy
- 21 October 2024
- Published by Wiley in Movement Disorders Clinical Practice
- Vol. 11 (12) , 1625-1628
Open AccessParkinsonism Associated with Anti‐B‐Cell Maturation Antigen Chimeric Antigen Receptor T‐Cell Therapy
- Open Access
- 12 March 2024
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 134 (9)
BAP1 is required prenatally for differentiation and maintenance of postnatal murine enteric nervous system
Epigenetic regulatory mechanisms are underappreciated, yet are critical for enteric nervous system (ENS) development and maintenance. We discovered that fetal loss of the epigenetic regulator Bap1 in the ENS lineage caused severe postnatal bowel dysfunction and early death in Tyrosinase-Cre Bap1 fl/fl mice. Bap1 -depleted ENS appeared normal in neonates; however, by P15, Bap1 -deficient enteric neurons were largely absent from the small and large intestine of Tyrosinase-Cre Bap1 fl/fl mice. Bowel motility became markedly abnormal with disproportionate loss of cholinergic neurons. Single-cell RNA sequencing at P5 showed that fetal Bap1 loss in Tyrosinase-Cre Bap1 fl/fl mice markedly altered the composition and relative proportions of enteric neuron subtypes. In contrast, postnatal deletion of Bap1 did not cause enteric neuron loss or impaired bowel motility. These findings suggest that BAP1 is critical for postnatal enteric neuron differentiation and for early enteric neuron survival, a finding that may be relevant to the recently described human BAP1-associated neurodevelopmental disorder.
- 12 March 2024
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 134 (9)
Open AccessBAP1 is required prenatally for differentiation and maintenance of postnatal murine enteric nervous system
Epigenetic regulatory mechanisms are underappreciated, yet are critical for enteric nervous system (ENS) development and maintenance. We discovered that fetal loss of the epigenetic regulator Bap1 in the ENS lineage caused severe postnatal bowel dysfunction and early death in Tyrosinase-Cre Bap1 fl/fl mice. Bap1 -depleted ENS appeared normal in neonates; however, by P15, Bap1 -deficient enteric neurons were largely absent from the small and large intestine of Tyrosinase-Cre Bap1 fl/fl mice. Bowel motility became markedly abnormal with disproportionate loss of cholinergic neurons. Single-cell RNA sequencing at P5 showed that fetal Bap1 loss in Tyrosinase-Cre Bap1 fl/fl mice markedly altered the composition and relative proportions of enteric neuron subtypes. In contrast, postnatal deletion of Bap1 did not cause enteric neuron loss or impaired bowel motility. These findings suggest that BAP1 is critical for postnatal enteric neuron differentiation and for early enteric neuron survival, a finding that may be relevant to the recently described human BAP1-associated neurodevelopmental disorder.
- Open Access
Single Nucleus Sequencing of Human Colon Visceral Smooth Muscle Cells, PDGFRα Cells, and Interstitial Cells of Cajal
Background and Aims: Smooth muscle cells (SMCs), Interstitial cells of Cajal (ICCs), and PDGFRα+ cells (PαCs) form a functional syncytium in the bowel known as the ‘SIP syncytium’. The SIP syncytium works in concert with the enteric nervous system (ENS) to coordinate bowel motility. However, our understanding of individual cell types that form this syncytium and how they interact with each other remains limited, with no prior single cell RNAseq analyses focused on human SIP syncytium cells. Methods: We analyzed single-nucleus RNA sequencing data from 10,749 human colon SIP syncytium cells (5572 SMC, 372 ICC, and 4805 PαC nuclei) derived from 15 individuals. Results: Consistent with critical contractile and pacemaker functions and with known ENS interactions, SIP syncytium cell types express many ion channels including mechanosensitive channels in ICCs and PαCs. PαCs also prominently express ECM-associated genes and the inhibitory neurotransmitter receptor for vasoactive intestinal peptide ( VIPR2 ), a novel finding. We identified two PαC clusters that differ in expression of many ion channels and transcriptional regulators. Interestingly, SIP syncytium cells co-express 6 transcription factors ( FOS , MEIS1 , MEIS2 , PBX1 , SCMH1 , and ZBTB16) that may be part of a combinatorial signature that specifies these cells. Bowel region-specific differences in SIP syncytium gene expression may correlate with regional differences in function, with right (ascending) colon SMCs and PαCs expressing more transcriptional regulators and ion channels than SMCs and PαCs in left (sigmoid) colon. Conclusion: These studies provide new insights into SIP syncytium biology that may be valuable for understanding bowel motility disorders and lead to future investigation of highlighted genes and pathways. Synopsis: In this first single nucleus RNASeq analysis of human SIP syncytium, we identify novel features of SIP syncytium cells, including two types of PDGFRα+ cells, a SIP-specific combinatorial transcription factor signature, and colon region differences in gene expression.
Open AccessSingle Nucleus Sequencing of Human Colon Visceral Smooth Muscle Cells, PDGFRα Cells, and Interstitial Cells of Cajal
Background and Aims: Smooth muscle cells (SMCs), Interstitial cells of Cajal (ICCs), and PDGFRα+ cells (PαCs) form a functional syncytium in the bowel known as the ‘SIP syncytium’. The SIP syncytium works in concert with the enteric nervous system (ENS) to coordinate bowel motility. However, our understanding of individual cell types that form this syncytium and how they interact with each other remains limited, with no prior single cell RNAseq analyses focused on human SIP syncytium cells. Methods: We analyzed single-nucleus RNA sequencing data from 10,749 human colon SIP syncytium cells (5572 SMC, 372 ICC, and 4805 PαC nuclei) derived from 15 individuals. Results: Consistent with critical contractile and pacemaker functions and with known ENS interactions, SIP syncytium cell types express many ion channels including mechanosensitive channels in ICCs and PαCs. PαCs also prominently express ECM-associated genes and the inhibitory neurotransmitter receptor for vasoactive intestinal peptide ( VIPR2 ), a novel finding. We identified two PαC clusters that differ in expression of many ion channels and transcriptional regulators. Interestingly, SIP syncytium cells co-express 6 transcription factors ( FOS , MEIS1 , MEIS2 , PBX1 , SCMH1 , and ZBTB16) that may be part of a combinatorial signature that specifies these cells. Bowel region-specific differences in SIP syncytium gene expression may correlate with regional differences in function, with right (ascending) colon SMCs and PαCs expressing more transcriptional regulators and ion channels than SMCs and PαCs in left (sigmoid) colon. Conclusion: These studies provide new insights into SIP syncytium biology that may be valuable for understanding bowel motility disorders and lead to future investigation of highlighted genes and pathways. Synopsis: In this first single nucleus RNASeq analysis of human SIP syncytium, we identify novel features of SIP syncytium cells, including two types of PDGFRα+ cells, a SIP-specific combinatorial transcription factor signature, and colon region differences in gene expression.
- Open Access
- 1 November 2020
- Published by Elsevier in Gastroenterology
- Vol. 159 (5) , 1824-1838.e17
Glial Cell-Derived Neurotrophic Factor Induces Enteric Neurogenesis and Improves Colon Structure and Function in Mouse Models of Hirschsprung Disease
- 1 November 2020
- Published by Elsevier in Gastroenterology
- Vol. 159 (5) , 1824-1838.e17
Open AccessGlial Cell-Derived Neurotrophic Factor Induces Enteric Neurogenesis and Improves Colon Structure and Function in Mouse Models of Hirschsprung Disease
- 24 September 2020
- Published by Elsevier in Gastroenterology
- Vol. 160 (4) , 1208-1223.e4
Sympathetic Input to Multiple Cell Types in Mouse and Human Colon Produces Region-Specific Responses
- 24 September 2020
- Published by Elsevier in Gastroenterology
- Vol. 160 (4) , 1208-1223.e4
Sympathetic Input to Multiple Cell Types in Mouse and Human Colon Produces Region-Specific Responses
- Open Access
- 20 August 2020
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 5 (16)
Pseudo-obstruction–inducing ACTG2R257C alters actin organization and function
Actin γ 2, smooth muscle ( ACTG2 ) R257C mutation is the most common genetic cause of visceral myopathy. Individuals with ACTG2 mutations endure prolonged hospitalizations and surgical interventions, become dependent on intravenous nutrition and bladder catheterization, and often die in childhood. Currently, we understand little about how ACTG2 mutations cause disease, and there are no mechanism-based treatments. Our goal was to characterize the effects of ACTG2 R257C on actin organization and function in visceral smooth muscle cells. We overexpressed ACTG2 WT or ACTG2 R257C in primary human intestinal smooth muscle cells (HISMCs) and performed detailed quantitative analyses to examine effects of ACTG2 R257C on (a) actin filament formation and subcellular localization, (b) actin-dependent HISMC functions, and (c) smooth muscle contractile gene expression. ACTG2 R257C resulted in 41% fewer, 13% thinner, 33% shorter, and 40% less branched ACTG2 filament bundles compared with ACTG2 WT . Curiously, total F-actin probed by phalloidin and a pan-actin antibody was unchanged between ACTG2 WT - and ACTG2 R257C -expressing HISMCs, as was ultrastructural F-actin organization. ACTG2 R257C -expressing HISMCs contracted collagen gels similar to ACTG2 WT -expressing HISMCs but spread 21% more and were 11% more migratory. In conclusion, ACTG2 R257C profoundly affects ACTG2 filament bundle structure, without altering global actin cytoskeleton in HISMCs.
- 20 August 2020
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 5 (16)
Open AccessPseudo-obstruction–inducing ACTG2R257C alters actin organization and function
Actin γ 2, smooth muscle ( ACTG2 ) R257C mutation is the most common genetic cause of visceral myopathy. Individuals with ACTG2 mutations endure prolonged hospitalizations and surgical interventions, become dependent on intravenous nutrition and bladder catheterization, and often die in childhood. Currently, we understand little about how ACTG2 mutations cause disease, and there are no mechanism-based treatments. Our goal was to characterize the effects of ACTG2 R257C on actin organization and function in visceral smooth muscle cells. We overexpressed ACTG2 WT or ACTG2 R257C in primary human intestinal smooth muscle cells (HISMCs) and performed detailed quantitative analyses to examine effects of ACTG2 R257C on (a) actin filament formation and subcellular localization, (b) actin-dependent HISMC functions, and (c) smooth muscle contractile gene expression. ACTG2 R257C resulted in 41% fewer, 13% thinner, 33% shorter, and 40% less branched ACTG2 filament bundles compared with ACTG2 WT . Curiously, total F-actin probed by phalloidin and a pan-actin antibody was unchanged between ACTG2 WT - and ACTG2 R257C -expressing HISMCs, as was ultrastructural F-actin organization. ACTG2 R257C -expressing HISMCs contracted collagen gels similar to ACTG2 WT -expressing HISMCs but spread 21% more and were 11% more migratory. In conclusion, ACTG2 R257C profoundly affects ACTG2 filament bundle structure, without altering global actin cytoskeleton in HISMCs.
- 27 February 2020
- Published by Elsevier in Gastroenterology
- Vol. 158 (8) , 2221-2235.e5
Robust, 3-Dimensional Visualization of Human Colon Enteric Nervous System Without Tissue Sectioning
- 27 February 2020
- Published by Elsevier in Gastroenterology
- Vol. 158 (8) , 2221-2235.e5
Robust, 3-Dimensional Visualization of Human Colon Enteric Nervous System Without Tissue Sectioning
- Open Access
- 27 February 2020
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 5 (4)
Dlx1/2 mice have abnormal enteric nervous system function
Decades ago, investigators reported that mice lacking DLX1 and DLX2, transcription factors expressed in the enteric nervous system (ENS), die with possible bowel motility problems. These problems were never fully elucidated. We found that mice lacking DLX1 and DLX2 ( Dlx1/2 –/– mice) had slower small bowel transit and reduced or absent neurally mediated contraction complexes. In contrast, small bowel motility seemed normal in adult mice lacking DLX1 ( Dlx1 –/– ). Even with detailed anatomic studies, we found no defects in ENS precursor migration, or neuronal and glial density in Dlx1/2 –/– or Dlx1 –/– mice. However, RNA sequencing of Dlx1/2 –/– ENS revealed dysregulation of many genes, including vasoactive intestinal peptide ( Vip ). Using immunohistochemistry and reporter mice, we then found that Dlx1/2 –/– mice have reduced VIP expression and fewer VIP-lineage neurons in their ENS. Our study reveals what we believe is a novel connection between Dlx genes and Vip and highlights the observation that dangerous bowel motility problems can occur in the absence of easily identifiable ENS structural defects. These findings may be relevant for disorders like chronic intestinal pseudo-obstruction (CIPO) syndrome.
- 27 February 2020
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 5 (4)
Open AccessDlx1/2 mice have abnormal enteric nervous system function
Decades ago, investigators reported that mice lacking DLX1 and DLX2, transcription factors expressed in the enteric nervous system (ENS), die with possible bowel motility problems. These problems were never fully elucidated. We found that mice lacking DLX1 and DLX2 ( Dlx1/2 –/– mice) had slower small bowel transit and reduced or absent neurally mediated contraction complexes. In contrast, small bowel motility seemed normal in adult mice lacking DLX1 ( Dlx1 –/– ). Even with detailed anatomic studies, we found no defects in ENS precursor migration, or neuronal and glial density in Dlx1/2 –/– or Dlx1 –/– mice. However, RNA sequencing of Dlx1/2 –/– ENS revealed dysregulation of many genes, including vasoactive intestinal peptide ( Vip ). Using immunohistochemistry and reporter mice, we then found that Dlx1/2 –/– mice have reduced VIP expression and fewer VIP-lineage neurons in their ENS. Our study reveals what we believe is a novel connection between Dlx genes and Vip and highlights the observation that dangerous bowel motility problems can occur in the absence of easily identifiable ENS structural defects. These findings may be relevant for disorders like chronic intestinal pseudo-obstruction (CIPO) syndrome.
- 10 February 2019
- Published by Annual Reviews in Annual Review of Physiology
- Vol. 81 (1) , 235-259
Unexpected Roles for the Second Brain: Enteric Nervous System as Master Regulator of Bowel Function
At the most fundamental level, the bowel facilitates absorption of small molecules, regulates fluid and electrolyte flux, and eliminates waste. To successfully coordinate this complex array of functions, the bowel relies on the enteric nervous system (ENS), an intricate network of more than 500 million neurons and supporting glia that are organized into distinct layers or plexi within the bowel wall. Neuron and glial diversity, as well as neurotransmitter and receptor expression in the ENS, resembles that of the central nervous system. The most carefully studied ENS functions include control of bowel motility, epithelial secretion, and blood flow, but the ENS also interacts with enteroendocrine cells, influences epithelial proliferation and repair, modulates the intestinal immune system, and mediates extrinsic nerve input. Here, we review the many different cell types that communicate with the ENS, integrating data about ENS function into a broader view of human health and disease. In particular, we focus on exciting new literature highlighting relationships between the ENS and its lesser-known interacting partners.
- 10 February 2019
- Published by Annual Reviews in Annual Review of Physiology
- Vol. 81 (1) , 235-259
Unexpected Roles for the Second Brain: Enteric Nervous System as Master Regulator of Bowel Function
At the most fundamental level, the bowel facilitates absorption of small molecules, regulates fluid and electrolyte flux, and eliminates waste. To successfully coordinate this complex array of functions, the bowel relies on the enteric nervous system (ENS), an intricate network of more than 500 million neurons and supporting glia that are organized into distinct layers or plexi within the bowel wall. Neuron and glial diversity, as well as neurotransmitter and receptor expression in the ENS, resembles that of the central nervous system. The most carefully studied ENS functions include control of bowel motility, epithelial secretion, and blood flow, but the ENS also interacts with enteroendocrine cells, influences epithelial proliferation and repair, modulates the intestinal immune system, and mediates extrinsic nerve input. Here, we review the many different cell types that communicate with the ENS, integrating data about ENS function into a broader view of human health and disease. In particular, we focus on exciting new literature highlighting relationships between the ENS and its lesser-known interacting partners.